About: Comparative effectiveness and safety of ribavirin plus interferon-alpha, lopinavir/ritonavir plus interferon-alpha, and ribavirin plus lopinavir/ritonavir plus interferon-alpha in patients with mild to moderate novel coronavirus disease 2019: study protocol

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Comparative effectiveness and safety of ribavirin plus interferon-alpha, lopinavir/ritonavir plus interferon-alpha, and ribavirin plus lopinavir/ritonavir plus interferon-alpha in patients with mild to moderate novel coronavirus disease 2019: study protocol Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Comparative effectiveness and safety of ribavirin plus interferon-alpha, lopinavir/ritonavir plus interferon-alpha, and ribavirin plus lopinavir/ritonavir plus interferon-alpha in patients with mild to moderate novel coronavirus disease 2019: study protocol
Creator	Chen, Yao-Kai Harypursat, Vijay He, Xiao-Qing Huang, Yin-Qiu Li, Yao Tang, Sheng-Quan Xu, Xiao-Lei Zeng, Yan-Ming
Source	Medline; PMC
abstract	covid:bef93c650da48ce4cdc89ddb30f35b4dfab2c5c4#abstract
has issue date	2020-05-05(xsd:dateTime)
bibo:doi	10.1097/cm9.0000000000000790
bibo:pmid	32149772
has license	cc-by-nc-nd
sha1sum (hex)	bef93c650da48ce4cdc89ddb30f35b4dfab2c5c4
schema:url	https://doi.org/10.1097/cm9.0000000000000790
resource representing a document's title	Comparative effectiveness and safety of ribavirin plus interferon-alpha, lopinavir/ritonavir plus interferon-alpha, and ribavirin plus lopinavir/ritonavir plus interferon-alpha in patients with mild to moderate novel coronavirus disease 2019: study protocol
has PubMed Central identifier	PMC7213617
has PubMed identifier	32149772
schema:publication	Chin Med J (Engl)
resource representing a document's body	covid:bef93c650da48ce4cdc89ddb30f35b4dfab2c5c4#body_text
is schema:about of	named entity 'lopinavir/ritonavir' named entity 'ribavirin' named entity 'dyspnea' named entity 'Clinical Trial' named entity 'COVID-19' named entity 'sputum' named entity 'serum' named entity 'radiographical' named entity 'nasopharyngeal' named entity 'SARS' named entity 'reliable clinical evidence' named entity 'ribavirin' named entity 'intravenous' named entity 'kidney disease' named entity 'COVID' named entity 'sputum' named entity 'COVID-19' named entity 'adverse events' named entity 'COVID' named entity 'case report' named entity 'COVID-19' named entity 'interferon-alpha' named entity 'hematological' named entity 'informed consent' named entity 'People's Republic of China' named entity 'ribavirin' named entity 'Chongqing' named entity 'coronavirus disease' named entity 'antiviral drugs' named entity 'aspirate' named entity 'Redmond, WA' named entity 'case report' named entity 'COVID' named entity 'dyspnea' named entity '2019-nCoV' named entity 'antiviral therapy' named entity 'antiviral' named entity '2019-nCoV' named entity 'adverse events' named entity 'COVID-19' named entity 'Chinese Medical Journal' named entity 'ribavirin' named entity 'RNA' named entity 'Microsoft' named entity 'inhalation' named entity 'X-ray' named entity 'antiviral therapy' named entity '2019-nCoV' named entity 'human immunodeficiency virus' named entity 'antiviral' named entity '2019-nCoV' named entity 'Randomized clinical trials' named entity 'chest imaging' named entity 'COVID' named entity 'computed tomography scan' named entity 'infection' named entity 'MERS' named entity '2019-nCoV' named entity 'creatinine clearance' named entity 'enzyme levels' named entity 'controlled clinical trial' named entity 'lopinavir/ritonavir' named entity 'alanine aminotransferase' named entity 'therapeutic drugs' named entity 'computed tomography scans' named entity '2019-nCov' named entity 'pneumonia' named entity 'genetically similar' named entity 'oropharyngeal' named entity 'clinical trials' named entity 'viral replication' named entity 'coronavirus infection' named entity 'RNA' named entity 'National Administration of Traditional Chinese Medicine'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software